SB-4826 in Adult Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphomas

NCT07222631 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Non Hodgkin Lymphoma
Solid Tumor

Interventions

DRUG: SB-4826
DRUG: Rituximab

Sponsor

University of California, San Diego

Collaborators

[object Object]